NF-κB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection

Immunology Letters

Volumn 127, Issue 1, 2009, Pages 19-26

  Calegari Silva, Teresa C ^a   Pereira, Renata M S ^a   De Melo, Luiz Dione Barbosa ^a,b   Saraiva, Elvira M ^a   Soares, Deivid C ^a   Bellio, Maria ^a   Lopes, Ulisses G ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO FEDERAL DE EDUCAÇÃO   (Brazil)

Author keywords

iNOS; Leishmania; Macrophage; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PROTEIN P50; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME REPRESSION; GENETIC TRANSCRIPTION; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; PROMASTIGOTE; PROMOTER REGION; REPORTER GENE; ANIMAL; CELL LINE; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; ENZYME REPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MICE; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTIONAL ACTIVATION;

EID: 70350743020     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.08.009     Document Type: Article

References (60)

1. WHO/TDR (World Health Organization/Tropical Diseases Researchers). http://www.who.int/tdr/diseases/leish/direction.htm#burden.
2. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol Rev 201 (2004) 206-224
3. Alexander J., and Russel D.G. The interaction of Leishmania species with macrophages. Adv Parasitol 31 (1992) 175-254
4. Gregory D.J., and Olivier M. Subversion of host signaling by the protozoan parasite Leishmania. Parasitology 130 (2005) S27-S35
5. Olivier M., Gregory D.J., and Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Med Rev 18 2 (2005) 293-305
6. Oswald I.P., Wynn T.A., Sher A., and James S.L. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 108 1 (1994) 11-18
7. Bodgan C. Nitric oxide and the immune response. Nat Immunol 2 (2001) 907-916
8. Green S.J., Nacy C.A., and Meltzer M.S. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol 50 (1991) 93-103
9. Liew F.Y., Millot S., Parkinson C., Palmer R.M.J., and Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from arginine. J Immunol 144 (1990) 4794-4797
10. Mauel J., Ransijn A., and Buchmuller-Rouller Y. Killing of Leishmania parasites in activated murine macrophages is based on an l-arginine-dependent process that produces nitrogen derivatives. J Leukoc Biol 49 (1991) 73-82
11. Stenger S., Thuring H., Röllinghoff M., and Bodgan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 180 (1994) 783-793
12. Wei X., Charles I.G., Smith A., Ure J., Feng G., Huang F., et al. Altered immune responses in mice lacking inducible nitric synthase. Nature 375 (1995) 408-411
13. Yamamoto Y., and Gaynor R.B. IκB kinases: key regulators of the NF-κB pathway. Trends Biochem Sci 29 2 (2004) 72-79
14. Xiao W. Advances in NF-κB signaling transduction and transcription. Cell Mol Immunol 1 6 (2004) 425-435
15. Perkins N.D. Integrating cell-signaling pathways with NF-κB and IKK function. Nat Rev 8 (2007) 49-62
16. Tato C.M., and Hunter C.A. Host-pathogen interaction: subversion and utilization of the NF-κB pathway during infection. Infect Immun 70 7 (2002) 331-3317
17. Guizani-Tabbane L., Ben-Aissa, Belghith M., Sassi A., and Dellagi K. Leishmania major amastigotes induce p50/cRel NF-κB transcription factor in human macrophages: involvement in cytokine synthesis. Infect Immun 72 5 (2004) 2582-2589
18. Singh V.K.M., Balaramn S., Tewary P., and Madhubala R. Leishmania donovani activates nuclear transcription factor-κB in macrophages through reactive oxygen intermediates. Biochem Biophys Res Commun 322 (2004) 1086-1095
19. Ghosh S., Bhattacharyya S., Suirkar M., Sa G.S., Das T., Majundar D., et al. Leishmania donovani suppresses activated protein 1 and NF-kappaB actication in host macrophages via ceramida generation: involvement of extracellular signal-regulated kinase. Infect Immun 70 (2002) 6828-6838
20. Prive C., and Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur J Immunol 30 (2000) 2235-2244
21. Argueta-Donohué J., Carrillo N., Valdés-Reyes L., Zentella A., Aguirre-García M., Becker I., et al. Leishmania mexicana: participation of NF-κB in the differential production of IL-12 in dendritic cells and monocytes induced by lipophosphoglycan (LPG). Exp Parasitol 120 (2008) 1-9
22. Silveira F.T., Lainson R., and Cobertt C.E.P. Clinical and immunopathological spectrum of American cutaneous Leishmaniasis with special reference to the disease in Amazonian Brazil-a review. Mem Inst Oswaldo Cruz 99 3 (2004) 239-251
23. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol 35 (2005) 1169-1180
24. + regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 174 (2005) 7147-7153
25. Ji J., Sun J., and Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 8 71 (2003) 4278-4288
26. Pereira R.M.S., Calegari-Silva T.C., Hernandez H.M.O., Saliba A.M., Redner P., Pessolani M.C.V., et al. Mycobacterium leprae induces NF-κB-dependent transcription repression in human Schwann cells. Biochem Biophys Res Commun 335 (2005) 20-26
27. Hayden M.S., and Ghosh S. Shared principles in NF-κB signaling. Cell 132 (2008) 344-362
28. Balestieri F.M.P., Queiroz A.R.P., Scavone C., Costa V.M., Barral-Netto M., and Abrahamsohn I.A. Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect 4 (2002) 23-29
29. Guo Z., Shao L., Du Q., Park K.S., and Geller D.A. Identification of a classic cytokine-induced upstream in the human iNOS promoter. FASEB J 21 (2007) 535-542
30. Taylor B.S., De Vera M.E., Ganster R.W., Wang Q., Shapiro R.A., Biiliar T.R., et al. A novel NF-κB enhancer element regulates cytokine induction of the human inducible nitric oxide synthase gene promoter. J Biol Chem 273 (1998) 15148-15156
31. De Vera M.E., Shapiro R.A., Nussler A.K., Mudgett J.S., Simmons R.L., Morris S.M., et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93 (1996) 1054-1059
32. Gregory D.J., Godbout M., Contreras I., Forget G., and Olivier M. A novel form of NF-κB is induced by Leishmania infection: involvement in macrophages gene expression. Eur J Immunol 38 (2008) 1071-1081
33. Ben-Othman R., Guizani-Tabbane L., and Dellagi K. Leishmania initially activates but subsequently down-regulates intracelular mitogen-activated protein kinases and nuclear factor-κB in macrophages. Mol Immunol 45 11 (2008) 3222-3229
34. Jayakumar A., Widenmaier R., Ma X., and McDowell M.A. Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages. J Parasitol 94 1 (2008) 84-93
35. Liese J., Schleicher U., and Bogdan C. The innate immune response against Leishmania parasites. Immunobiology 213 (2008) 377-387
36. Denkers E.Y., and Butcher B.A. Sabotage and exploitation in macrophages parasitized by intracellular protozoan. Trends Parasitol 21 1 (2005) 35-41
37. Cameron P., McGachy A., Anderson M., Paul A., Coombs G.H., Mottram J.C., et al. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-κB signaling pathway. J Immunol 173 (2004) 3297-3304
38. Guedes H.L., Rezende J.M., Fonseca M.A., Salles C.M., Rossi-Bergmann B., and De-Simone S.G. Identification of serine proteases from Leishmania braziliensis. Z Naturforsch C 62 5-6 (2007) 373-381
39. Da Silva-Lopez R.E., and Giovanni-De-Simone S. Leishmania (Leishmania) amazonensis: purification and characterization of a promastigote serine protease. Exp Parasitol 107 3-4 (2004) 173-182
40. Silva-Lopez R.E., Coelho M.G., and De Simone S.G. Characterization of an extracellular serine protease of Leishmania (Leishmania) amazonensis. Parasitology 31 1 (2005) 85-96
41. Svensjö E., Batista P.R., Brodskyn C.I., Silva R., Lima A.P., Schmitz V., et al. Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex. Microbes Infect 8 1 (2006) 206-220
42. Mottram J., Coombs G.H., and Alexander J. Cysteíne peptidases as virulence factors of Leishmania. Curr Opin Microbiol 7 (2004) 375-381
43. Araujo Soares R.M., Dos Santos A.L., Bonaldo M.C., De Andrade A.F., Alviano C.S., Angluster J., et al. Leishmania (Leishmania) amazonensis: differential expression of proteinases and cell-surface polypeptides in avirulent and virulent promastigotes. Exp Parasitol 104 (2003) 104-112
44. Liew F.Y., Li Y., Moss D., Parkinson C., Rogers M.V., and Moncada S. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol 21 (1991) 3009-3014
45. Green S.J., Meltzer M.S., Hibbs Jr. J.B., and Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by an l-arginine-dependent killing mechanism. J Immunol 144 (1990) 278-283
46. Li Y., Severn A., Rogers M.V., Palmer R.M., Moncada S., and Liew F.Y. Catalase inhibits nitric oxide synthesis and the killing of intracellular Leishmania major in murine macrophages. Eur J Immunol 22 (1992) 441-446
47. Assreuy J., Cunha F.Q., Epperlein M., Noronha-Dutra A., O'Donnell C.A., Liew F.Y., et al. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol 24 (1994) 672-676
48. Proudfoot L., O'Donnell C.A., and Liew F.Y. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol 25 (1995) 745-750
49. Proudfoot L., Nikolaev A.V., Feng G.J., Wei W.Q., Ferguson M.A., Brimacombe J.S., et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci USA 93 (1996) 10984-10989
50. Qadoumi M., Becker I., Donhauser N., Rollinghoff M., and Bogdan C. Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect Immun 70 (2002) 4638-4642
51. Arevalo I., Ward B., and Matlashewski G. Detection of iNOS gene expression in cutaneous leishmaniasis biopsy tissue. Mol Biochem Parasitol 121 (2002) 145-147
52. Díaz N.L., Fernández M., Figueira E., Ramírez R., Monsalve I.B., and Tapia F.J. Nitric oxide and cellular immunity in experimental cutaneous Leishmaniasis. Clin Exp Dermatol 28 (2003) 288-293
53. Winberg M.E., Rasmusson B., and Sundqvist T. Leishmania donovani: inhibition of phagosomal maturation is rescued by nitric oxide in macrophages. Exp Parasitol 117 (2007) 165-170
54. Mukbel R.M., Calvin Patten J.R., Gibson K., Ghosh M., Petersen C., and Jones D.E. Macrophage killing of Leishmania amazonensis Amastigotes requires both nitric oxide and superoxide. Am J Trop Med Hyg 76 4 (2007) 669-675
55. Olivier M., Romero-Gallo B.J., Matte C., Blanchette J., Posner B.I., Tremblay M.J., et al. Modulation of interferon-gamma induced macrophage activation by phosphotyrosine phosphatases inhibition-effect on murine Leishmaniasis progression. J Biol Chem 273 (1998) 13944-13949
56. Blanchette J., Abu-Dayyeh I., Hassani K., Whitcombe L., and Olivier M. Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1). Immunology 127 (2009) 123-133
57. Matte C., Marquis J.F., Blanchette J., Gros P., Faure R., Posner B.I., et al. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur J Immunol 30 (2000) 2555-2564
58. Forget G., Siminovitch K.A., Brochu S., Rivest S., Radzioch D., and Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol 31 (2001) 3185-3196
59. Forget G., Gregory D.J., Whitcombe L.A., and Olivier M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect Immun 74 11 (2006) 6272-6279
60. Blanchette J., Pouliot P., and Olivier M. Role of protein tyrosine phosphatases in the regulation of interferon-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation. J Leukoc Biol 81 (2007) 835-844